SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5CP'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FMO_E_ADNE351_1 (CAMP-DEPENDENTPROTEIN KINASE) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 7 / 12 | VAL A 28ALA A 41VAL A 74VAL A 93ASN A 141LEU A 143ASP A 157 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)5CP A 600 ( 4.7A)5CP A 600 ( 3.7A)None5CP A 600 (-4.4A)5CP A 600 (-3.5A) | 0.74A | 1fmoE-3bhhA:22.8 | 1fmoE-3bhhA:29.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EUF_B_LQQB401_1 (CELL DIVISIONPROTEIN KINASE 6) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 7 / 12 | VAL A 28PHE A 90VAL A 93ASN A 141LEU A 143ALA A 156ASP A 157 | 5CP A 600 ( 4.4A)5CP A 600 ( 4.3A)5CP A 600 ( 3.7A)None5CP A 600 (-4.4A)5CP A 600 ( 3.9A)5CP A 600 (-3.5A) | 0.74A | 2eufB-3bhhA:27.4 | 2eufB-3bhhA:31.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EUF_B_LQQB401_1 (CELL DIVISIONPROTEIN KINASE 6) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 7 / 12 | VAL A 28VAL A 74PHE A 90ASN A 141LEU A 143ALA A 156ASP A 157 | 5CP A 600 ( 4.4A)5CP A 600 ( 4.7A)5CP A 600 ( 4.3A)None5CP A 600 (-4.4A)5CP A 600 ( 3.9A)5CP A 600 (-3.5A) | 0.62A | 2eufB-3bhhA:27.4 | 2eufB-3bhhA:31.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LFA_A_1N1A361_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 14) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 4 / 8 | ALA A 41GLU A 61LEU A 88LEU A 92 | 5CP A 600 (-3.6A)NoneNone5CP A 600 (-4.6A) | 0.42A | 3lfaA-3bhhA:22.1 | 3lfaA-3bhhA:29.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_A_1N1A1000_2 (P38A) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 3 / 3 | GLU A 61LEU A 88LEU A 92 | NoneNone5CP A 600 (-4.6A) | 0.62A | 3ohtA-3bhhA:5.9 | 3ohtA-3bhhA:28.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OHT_B_1N1B1000_2 (P38A) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 3 / 3 | GLU A 61LEU A 88LEU A 92 | NoneNone5CP A 600 (-4.6A) | 0.65A | 3ohtB-3bhhA:5.8 | 3ohtB-3bhhA:28.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI1_A_B49A299_1 (CYCLIN-DEPENDENTKINASE 2) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 5 / 9 | ALA A 41VAL A 74PHE A 90LEU A 143ASP A 157 | 5CP A 600 (-3.6A)5CP A 600 ( 4.7A)5CP A 600 ( 4.3A)5CP A 600 (-4.4A)5CP A 600 (-3.5A) | 0.77A | 3ti1A-3bhhA:23.7 | 3ti1A-3bhhA:31.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 6 / 12 | VAL A 28ALA A 41GLU A 61ILE A 64LEU A 143ALA A 156 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)NoneNone5CP A 600 (-4.4A)5CP A 600 ( 3.9A) | 0.86A | 4bkjA-3bhhA:23.0 | 4bkjA-3bhhA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 6 / 12 | VAL A 28ALA A 41GLU A 61ILE A 64LEU A 143ALA A 156 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)NoneNone5CP A 600 (-4.4A)5CP A 600 ( 3.9A) | 0.84A | 4bkjB-3bhhA:22.9 | 4bkjB-3bhhA:25.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_A_0LIA1772_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 6 / 12 | VAL A 28ALA A 41GLU A 61CYH A 127HIS A 134ALA A 156 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)NoneNoneNone5CP A 600 ( 3.9A) | 1.27A | 4v04A-3bhhA:22.6 | 4v04A-3bhhA:26.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L2I_A_LQQA900_1 (CYCLIN-DEPENDENTKINASE 6) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 7 / 12 | VAL A 28ALA A 41VAL A 74PHE A 90LEU A 143ALA A 156ASP A 157 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)5CP A 600 ( 4.7A)5CP A 600 ( 4.3A)5CP A 600 (-4.4A)5CP A 600 ( 3.9A)5CP A 600 (-3.5A) | 0.63A | 5l2iA-3bhhA:7.6 | 5l2iA-3bhhA:30.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENTKINASE 6) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 7 / 12 | VAL A 28ALA A 41VAL A 74PHE A 90LEU A 143ALA A 156ASP A 157 | 5CP A 600 ( 4.4A)5CP A 600 (-3.6A)5CP A 600 ( 4.7A)5CP A 600 ( 4.3A)5CP A 600 (-4.4A)5CP A 600 ( 3.9A)5CP A 600 (-3.5A) | 0.77A | 5l2tA-3bhhA:7.4 | 5l2tA-3bhhA:30.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) |
3bhh | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE II BETACHAIN (Homosapiens) | 4 / 4 | VAL A 74LEU A 92ASN A 141ASP A 157 | 5CP A 600 ( 4.7A)5CP A 600 (-4.6A)None5CP A 600 (-3.5A) | 0.86A | 5vcyA-3bhhA:25.3 | 5vcyA-3bhhA:26.35 |